High levels of this chemokine have been described in pathological loci, such as the submucosa and muscularis of Crohn’s disease (CD)21, and the MCP1‐A2518G polymorphism is considered a protective factor for inflammatory bowel disease (IBD) in European populations22. Here, CCL2 is linked to inflammatory bowel disease.